• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    凯

    凯撒永久华盛顿健康研究所

    Kaiser Permanente Washington Health Research Institute
    EST. 1983
    5,834论文总数
    25.5万引用总数

    论文量&引用量时间轴

    机构学者

    论文(5834)

    年份
    起
    –
    止
    排序
    1Ischemic Stroke after Bivalent Mrna COVID-19 Vaccination and Influenza Vaccination During the 2022–2023 Season: a Multi-Site Self-Controlled Case Series Study
    Stanley Xu,Lina S. Sy,Vennis Hong,Paddy Farrington,Sungching C. Glenn,Sunhea Kim,Denison S. Ryan,Julia E. Tubert, Paulina Tong,Bruno J. Lewin,Hung Fu Tseng, Alexandra Carbayo,

    Background The Vaccine Safety Datalink (VSD) detected a statistical signal for ischemic events (ischemic stroke or transient ischemic attack) following bivalent mRNA COVID-19 vaccination through prospective surveillance during 2022–2023. Although multiple studies from other surveillance systems and countries reported no increased risk, important methodological limitations remained. This U.S. study addressed those limitations by evaluating the ischemic stroke risk following bivalent mRNA COVID-19 vaccination, influenza vaccination, and their same-day coadministration using an event-dependent self-controlled case series (SCCS) design. Methods Study outcomes included first-ever ischemic stroke (primary outcome), first-in-1-year ischemic stroke (secondary outcome), and ischemic events (exploratory outcomes), identified using ICD-10-CM codes in inpatient and emergency department settings during September 1, 2022–March 31, 2023, among individuals aged ≥12 years across eight VSD sites. Analyses were conducted separately for Pfizer-BioNTech and Moderna bivalent vaccines, with relative incidences (RI) and 95% confidence intervals (CI) estimated for 1–21-day and 1–42-day risk intervals, using person-time outside these intervals as the control period. Subgroup analyses were performed by age group (12–64, ≥65 years) and history of documented SARS-CoV-2 infection. Results A total of 6510 first-ever ischemic strokes were identified among more than 6.8 million participants. Among recipients of Pfizer-BioNTech bivalent COVID-19 and influenza vaccines, no statistically significant increased risk of first-ever ischemic stroke was observed following bivalent COVID-19 vaccination (RI = 0.94; 95% CI: 0.63–1.41), influenza vaccination (RI = 0.95; 95% CI: 0.82–1.10), or same-day coadministration (RI = 1.15; 95% CI: 0.88–1.49) within 1–21-day risk intervals; findings were similar for 1–42-day intervals. Comparable null results were observed for Moderna vaccine and across all subgroups, secondary, and exploratory outcomes. Conclusion No increased risk of ischemic stroke was found following bivalent mRNA COVID-19 vaccination, influenza vaccination, or their coadministration in this multi-site SCCS study. These findings are consistent with previous studies and underscore the importance of continued vaccine safety monitoring.

    2027Vaccine(2027)
    引用
    AI阅读
    加入学术空间
    2Preventing Severe Hypoglycemia in Type 2 Diabetes: Randomized Controlled Trial of Proactive Care with Versus Without Psychoeducation.
    James D. Ralston, Melissa L. Anderson, Janet Ng,Ayat Bashir,Kelly Ehrlich, Dena Burns-Hunt, Meredith Cotton, Laurel Hansell,Clarissa Hsu, Helen Hunt,Andrew J. Karter, Shaula M. Levy,

    Severe hypoglycemia is a feared complication of diabetes treatment. While psychoeducational programs reduce severe hypoglycemia in type 1 diabetes, their effectiveness is unclear in type 2 diabetes (T2D). The Preventing Severe Hypoglycemia in Adults with Type 2 Diabetes (PHT2) randomized trial compared (a) proactive nurse care management (PC) and (b) PC augmented with my hypo compass for adults with T2D, a psychoeducational intervention (PC+). Adults with T2D on insulin or sulfonylurea and with a severe event in the prior 12 months or impaired awareness of hypoglycemia. Primary outcome was self-reported severe hypoglycemia over 12 months, assessed at 14 months. Ninety-two percent (n = 230) of 259 participants (67.2 ± 10.6 years; 61

    2026Journal of General Internal Medicine(2026)引用:33
    引用
    AI阅读
    加入学术空间
    3Increased Risk of Type I Errors for Detecting Heterogeneity of Treatment Effects in Cluster-Randomized Trials Using Mixed-Effect Models
    Noorie Hyun,Abisola E Idu,Andrea J. Cook,Jennifer F. Bobb

    BACKGROUND/AIMS: Evaluating heterogeneity of treatment effects (HTE) across subgroups is common in both randomized trials and observational studies. Although several statistical challenges of HTE analyses including low statistical power and multiple comparisons are widely acknowledged, issues specific to clustered data, including cluster randomized trials (CRTs), have received less attention. For testing interactions in linear mixed-effects models (LMM), Barr et al. (2013) suggested that: random slopes for interaction terms should be studied. In this paper, we explore the impact of model misspecification, including generalized LMM (GLMM) with or without random slopes, and provide recommendations for conducting inference for HTE across subgroups in CRTs. METHODS: We conducted a simulation study to evaluate the performance of common analytic approaches for testing the presence of HTE for continuous, binary, and count outcomes: generalized linear mixed models (GLMM) and generalized estimating equations (GEE) including interaction terms between treatment and subgroup. Several simulation scenarios covered broad range of scenarios in CRTs, for example, small to a large number of clusters, small to moderate cluster-specific random slopes for subgroup. The performance metric was the empirical type I error rate compared to a nominal level. We applied the analytical methods to a real-world CRT using the count outcome utilization of healthcare from the motivating Primary Care Opioid Use Disorder treatment (PROUD) trial. RESULTS: We found that standard GLMM analyses that assume a common correlation of participants within clusters can lead to severely elevated type 1 error rates of up to 47.2% compared to the 5% nominal level if the within-cluster correlation varies across subgroups. A maximal GLMM, which allows subgroup-specific within-cluster correlations, achieved the nominal type 1 error rate, as did GEE (though rates were slightly elevated even with as many as 50 clusters). Applying the methods to the real-world CRT, we found a large impact of the model specification on inference. CONCLUSIONS: We recommend that HTE analyses using the maximal GLMM account for within-subgroup correlation to avoid anti-conservative inference. For Wald t-testing of HTE in small sample clusters, appropriate small sample correction methods should be considered based on the outcome data type.

    2026BMC Medical Research Methodology(2026)引用:7
    引用
    AI阅读
    加入学术空间
    4Overview of Risk Factors for Cardiovascular Disease
    Eileen Rillamas-Sun,Jeannette M. Beasley, Eric T. Hyde,Andrea Z. LaCroix
    2026Women and Health(2026)引用:3
    引用
    AI阅读
    加入学术空间
    5Efficient Targeted Maximum Likelihood Estimators for Two-Phase Design Problems
    Sky Qiu,Susan Gruber, Pamela A. Shaw, Brian D. Williamson, Mark J. van der Laan

    In a typical two-phase design, a random sample is drawn from the target population in phase 1, during which only a subset of variables is collected. In phase 2, a subsample of the phase-1 cohort is selected, and additional variables are measured. This setting induces a coarsened data structure on the data from the second phase. We assume coarsening at random, that is, the phase-2 sampling mechanism depends only on variables fully observed. We review existing estimators, including the generalized raking estimator and the inverse probability of censoring weighted targeted maximum likelihood estimation (IPCW-TMLE) along with its extensions that also target the phase-2 sampling mechanism to improve efficiency. We further introduce a new class of estimators constructed within the TMLE framework that are asymptotically equivalent.

    2026引用:3
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 5834 篇论文

    合作机构(100)

    华盛顿大学合作论文 1,363
    加州大学旧金山分校合作论文 204
    密歇根大学合作论文 187
    Kaiser Permanente Center for Health Research合作论文 166
    范德比尔特大学合作论文 162
    北卡罗来纳大学系统合作论文 156
    匹兹堡大学合作论文 150
    杜克大学合作论文 147
    加利福尼亚大学圣地亚哥分校合作论文 144
    哈佛大学合作论文 136

    机构统计